|
ZNF84 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.26659999658096E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.44019999998224E-06 |
| Normal-vs-Stage2 |
1.158970E-01 |
| Normal-vs-Stage3 |
1.103390E-01 |
| Normal-vs-Stage4 |
1.318790E-01 |
| Stage1-vs-Stage2 |
7.688800E-01 |
| Stage1-vs-Stage3 |
2.095400E-01 |
| Stage1-vs-Stage4 |
8.263400E-01 |
| Stage2-vs-Stage3 |
5.661400E-01 |
| Stage2-vs-Stage4 |
9.949800E-01 |
| Stage3-vs-Stage4 |
5.466200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.42890000019025E-08 |
| Normal-vs-AfricanAmerican |
1.425780E-04 |
| Normal-vs-Asian |
5.187200E-01 |
| Caucasian-vs-AfricanAmerican |
8.360000E-01 |
| Caucasian-vs-Asian |
1.776140E-02 |
| AfricanAmerican-vs-Asian |
2.016200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.0900000042885E-08 |
| Normal-vs-Female |
6.10319999999609E-05 |
| Male-vs-Female |
7.425200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.300400E-03 |
| Normal-vs-Extreme_Weight |
1.283330E-03 |
| Normal-vs-Obese |
4.00219999999729E-05 |
| Normal-vs-Extreme_Obese |
1.952440E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.686800E-01 |
| Normal_Weight-vs-Obese |
2.266800E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.825800E-01 |
| Extreme_Weight-vs-Obese |
1.804560E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.661000E-01 |
| Obese-vs-Extreme_Obese |
4.744800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.160100E-03 |
| Normal-vs-Age(41-60Yrs) |
6.75739997291203E-09 |
| Normal-vs-Age(61-80Yrs) |
5.95839999999459E-05 |
| Normal-vs-Age(81-100Yrs) |
3.845600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.085400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.231600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.764200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.027700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.113040E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.441200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.66338079263551E-12 |
| Normal-VS-Type2 PRCC |
7.239000E-01 |
| Normal-VS-KIRP CIMP |
9.962400E-01 |
| Normal-VS-Unclassified PRCC |
2.976100E-03 |
| Type1 PRCC-VS-Type2 PRCC |
3.783300339677E-10 |
| Type1 PRCC-VS-KIRP CIMP |
1.150480E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.170600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.670800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.939600E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
8.767600E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.747800E-02 |
| Normal-vs-N1 |
3.818000E-03 |
| Normal-vs-N2 |
7.343600E-01 |
| N0-vs-N1 |
8.404100E-02 |
| N0-vs-N2 |
6.409600E-01 |
| N1-vs-N2 |
2.600000E-01 |
|
|
